Michael B. Paumen
No más puestos en curso
Perfil
Michael B.
Paumen served as the Chief Executive Officer of Dx assays Pte Ltd.
He also held the position of Chief Executive Officer at Biolidics Ltd.
Prior to that, he worked as the Technical Director at Affymetrix, Inc. and as the Manager-Scientific Affairs at Qiagen, Inc. Paumen holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Antiguos cargos conocidos de Michael B. Paumen.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOLIDICS LIMITED | Director Ejecutivo | 23/03/2020 |
| AFFYMETRIX, INC. | Director Técnico/Científico/I+D | - |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Director Técnico/Científico/I+D | - |
Dx assays Pte Ltd.
 Dx assays Pte Ltd. Medical SpecialtiesHealth Technology Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003. | Presidente | - |
Formación de Michael B. Paumen.
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOLIDICS LIMITED | Health Technology |
| Empresas privadas | 3 |
|---|---|
Dx assays Pte Ltd.
Dx assays Pte Ltd. Medical SpecialtiesHealth Technology Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael B. Paumen
